Proteomic and Metabolomic Profiling via Mass Spectrometry in Multiple Myeloma: A Comprehensive Review of Prognostic Biomarkers and Monitoring of Minimal Residual Disease - Quiz - MDSpire

Proteomic and Metabolomic Profiling via Mass Spectrometry in Multiple Myeloma: A Comprehensive Review of Prognostic Biomarkers and Monitoring of Minimal Residual Disease

  • By

  • Naseel Moursy

  • Hibba Siraj

  • Zainab Nasir

  • Affaf Tanweer

  • Muhammad Raihan Sajid

  • April 22, 2026

  • 0 min

Share

Original Source(s)

Proteomic and Metabolomic Profiling via Mass Spectrometry in Multiple Myeloma: A Comprehensive Review of Prognostic Biomarkers and Monitoring of Minimal Residual Disease

  • by Naseel Moursy, Hibba Siraj, Zainab Nasir, Affaf Tanweer, Muhammad Raihan Sajid

  • April 22, 2026

Related Content

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

Exploring the Therapeutic Promise of γδ T Cells in Blood Disorders: Bridging Immunobiology and Clinical Innovation

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study